Insurers, PBMs nudge FDA to finalize interchangeability guidance

More than a dozen healthcare organizations, including the Campaign for Sustainable Rx Pricing (CSRxP), are calling for Food and Drug Administration Commissioner Scott Gottlieb to finalize guidance on interchangeable biosimilars.